ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,615.35
      0.55%
      US Tech 100
      19,788.80
      0.57%
      Dow Jones
      40,000.90
      0.62%
      Brent Oil
      84.625
      -0.57%
      Bitcoin
      57,277.59
      -0.13%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. (MM) (IDIX)

      7. (MM) (IDIX) News

      IDIX

      (MM) (IDIX)

      (MM)
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:IDIX
      DateTimeSourceHeadlineSymbolCompany
      01/05/20114:05PMPR Newswire (US)Idenix Pharmaceuticals to Present at the 29th Annual J.P. Morgan Healthcare ConferenceNASDAQ:IDIX(MM)
      12/30/20108:01AMEdgar (US Regulatory)Current report filing (8-K)NASDAQ:IDIX(MM)
      12/06/20104:07PMEdgar (US Regulatory)Current report filing (8-K)NASDAQ:IDIX(MM)
      11/26/20107:49AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IDIX(MM)
      11/23/20104:09PMEdgar (US Regulatory)Current report filing (8-K)NASDAQ:IDIX(MM)
      11/23/20108:00AMPR Newswire (US)Idenix Pharmaceuticals Announces $20 Million Milestone Payment From ViiV Healthcare for Initiation of Phase IIb Trial of '761NASDAQ:IDIX(MM)
      11/02/20104:06PMEdgar (US Regulatory)Current report filing (8-K)NASDAQ:IDIX(MM)
      11/01/20104:07PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IDIX(MM)
      11/01/20103:12PMEdgar (US Regulatory)Quarterly Report (10-Q)NASDAQ:IDIX(MM)
      10/29/20104:15PMEdgar (US Regulatory)Current report filing (8-K)NASDAQ:IDIX(MM)
      10/29/20104:05PMPR Newswire (US)Idenix Pharmaceuticals Reports Third Quarter and Nine Month 2010 Financial ResultsNASDAQ:IDIX(MM)
      10/28/20109:00AMPR Newswire (US)Idenix Pharmaceuticals Announces Ronald C. Renaud, Jr. Named President, Chief Executive Officer and Member of the Board of DirecNASDAQ:IDIX(MM)
      10/27/20104:05PMPR Newswire (US)Idenix Pharmaceuticals to Hold an Investor/Analyst Day Event on October 30, 2010NASDAQ:IDIX(MM)
      10/26/20104:05PMPR Newswire (US)Idenix Pharmaceuticals to Present at an Upcoming Investor ConferenceNASDAQ:IDIX(MM)
      10/13/20104:31PMEdgar (US Regulatory)Current report filing (8-K)NASDAQ:IDIX(MM)
      10/13/20104:09PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IDIX(MM)
      10/13/20104:07PMEdgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:IDIX(MM)
      10/01/20109:55AMPR Newswire (US)Idenix Announces Data Presentations at the 61st Annual Meeting of the American Association for the Study of Liver Diseases (AASLNASDAQ:IDIX(MM)
      09/20/20104:17PMPR Newswire (US)Idenix Pharmaceuticals to Present at Four Upcoming Investor ConferencesNASDAQ:IDIX(MM)
      09/16/20102:37PMEdgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/A)NASDAQ:IDIX(MM)
      09/07/20104:05PMPR Newswire (US)Idenix Pharmaceuticals to Present at Two Upcoming Investor ConferencesNASDAQ:IDIX(MM)
      09/07/20108:03AMDow Jones NewsIdenix Says FDA Put Studies Of Hepatitis C Drug On HoldNASDAQ:IDIX(MM)
      09/07/20107:01AMEdgar (US Regulatory)Current report filing (8-K)NASDAQ:IDIX(MM)
      09/07/20107:00AMPR Newswire (US)Idenix Provides Update on HCV Clinical Development ActivitiesNASDAQ:IDIX(MM)
      08/23/20102:49PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IDIX(MM)
      08/13/20104:36PMEdgar (US Regulatory)Current report filing (8-K)NASDAQ:IDIX(MM)
      07/27/20104:05PMPR Newswire (US)Idenix Pharmaceuticals to Present at Two Upcoming Investor ConferencesNASDAQ:IDIX(MM)
      07/27/201012:15PMEdgar (US Regulatory)Quarterly Report (10-Q)NASDAQ:IDIX(MM)
      07/26/20104:22PMEdgar (US Regulatory)Current report filing (8-K)NASDAQ:IDIX(MM)
      07/26/20104:05PMPR Newswire (US)Idenix Pharmaceuticals Reports Second Quarter 2010 Financial Results and Provides Research and Development Update on HCV ProgramNASDAQ:IDIX(MM)
       Showing the most relevant articles for your search:NASDAQ:IDIX